Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Net Margin (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Net Margin for 13 consecutive years, with 26.17% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 2590.0% year-over-year to 26.17%, compared with a TTM value of 28.34% through Dec 2025, down 1813.0%, and an annual FY2025 reading of 2588.97%, up 259919.0% over the prior year.
  • Net Margin was 26.17% for Q4 2025 at Tandem Diabetes Care, up from 8.51% in the prior quarter.
  • Across five years, Net Margin topped out at 26.17% in Q4 2025 and bottomed at 73.13% in Q1 2023.
  • Average Net Margin over 5 years is 13.48%, with a median of 9.02% recorded in 2025.
  • The sharpest move saw Net Margin tumbled -6478bps in 2023, then soared 5085bps in 2024.
  • Year by year, Net Margin stood at 5.15% in 2021, then tumbled by -240bps to 7.21% in 2022, then crashed by -112bps to 15.25% in 2023, then skyrocketed by 102bps to 0.27% in 2024, then soared by 9697bps to 26.17% in 2025.
  • Business Quant data shows Net Margin for TNDM at 26.17% in Q4 2025, 8.51% in Q3 2025, and 21.77% in Q2 2025.